PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy StudyGlobeNewsWire • 08/20/24
PainReform Announces Favorable Safety Profile of PRF-110, Indicating Potential for Use in New Surgical Applications Requiring Higher DosesGlobeNewsWire • 08/07/24
PainReform's New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room TemperatureGlobeNewsWire • 08/01/24
PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.comGlobeNewsWire • 05/08/24
PainReform's Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing ConditionsGlobeNewsWire • 04/09/24
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in BunionectomyGlobeNewsWire • 04/02/24
PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain ReliefGlobeNewsWire • 01/03/24
PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross ProceedsGlobeNewsWire • 12/26/23
PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master FileGlobeNewsWire • 09/11/23
PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, HungaryGlobeNewsWire • 09/07/23
PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York CityGlobeNewsWire • 09/05/23
PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private PlacementGlobeNewsWire • 07/14/23
PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private PlacementGlobeNewsWire • 07/12/23
PainReform to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21stGlobeNewsWire • 06/15/23